Comparison of Outcomes of Percutaneous Mechanical Aspiration vs Tricuspid Valve Surgery in Drug Use-Associated Endocarditis of the Tricuspid Valve
- PMID: 40376191
- PMCID: PMC12079652
- DOI: 10.1093/ofid/ofaf259
Comparison of Outcomes of Percutaneous Mechanical Aspiration vs Tricuspid Valve Surgery in Drug Use-Associated Endocarditis of the Tricuspid Valve
Abstract
Background: People who inject drugs (PWID) and present with infective endocarditis (IE) of the tricuspid valve may need valve surgery due to persistent infection, heart failure, or embolic risk. Vacuum-assisted percutaneous mechanical aspiration (PMA) has been proposed as a potential option for those who cannot undergo surgery.
Methods: We queried TriNetX, a database that provides access to electronic medical record data across health care organizations, to identify PWID who had tricuspid valve IE and underwent PMA between 2016 and 2024, using diagnostic and procedure codes. Short-term procedural and clinical outcomes were compared with PWID who underwent tricuspid valve surgery.
Results: In total, 129 patients underwent the PMA procedure and 952 had valve surgery. A higher proportion of the PMA cohort was female (66% vs 57%) and of non-White race (32% vs 22.5%). At 1 month postprocedure, the surgical group had a lower rate of death (2.5% vs 7.9%, P = .001), while the PMA group had a lower risk of heart block or need for pacemaker implantation (0% vs 4%). After propensity matching between groups, these differences were not significant. At 1 year postprocedure, groups had similar rates of heart failure, tricuspid insufficiency, or offer of treatment intervention for opioid use disorder.
Conclusions: Short-term outcomes seem comparable between PMA and tricuspid valve surgery in tricuspid valve IE in PWID. Additional studies with larger cohort numbers are needed to further evaluate the difference in long-term postoperative outcomes between the groups.
Keywords: AngioVac; PWID; percutaneous mechanical aspiration; tricuspid endocarditis; tricuspid valve replacement.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. S. N. reports investigator-initiated grant funding from Melinta Therapeutics. All other authors report no potential conflicts.
Figures
Similar articles
-
Percutaneous Mechanical Aspiration vs Valve Surgery for Tricuspid Valve Endocarditis in People Who Inject Drugs.Ann Thorac Surg. 2021 May;111(5):1451-1457. doi: 10.1016/j.athoracsur.2020.08.036. Epub 2020 Oct 20. Ann Thorac Surg. 2021. PMID: 33096075
-
Comparison of Medical Therapy, Valve Surgery, and Percutaneous Mechanical Aspiration for Tricuspid Valve Infective Endocarditis.Am J Med. 2024 Sep;137(9):888-895.e2. doi: 10.1016/j.amjmed.2024.04.031. Epub 2024 May 9. Am J Med. 2024. PMID: 38729593
-
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors.Intern Emerg Med. 2024 Mar;19(2):455-464. doi: 10.1007/s11739-023-03502-6. Epub 2023 Dec 21. Intern Emerg Med. 2024. PMID: 38129537
-
Surgical Management of Tricuspid Valve Infective Endocarditis: A Systematic Review and Meta-Analysis.Ann Thorac Surg. 2018 Sep;106(3):708-714. doi: 10.1016/j.athoracsur.2018.04.012. Epub 2018 May 8. Ann Thorac Surg. 2018. PMID: 29750928
-
Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis.Clin Infect Dis. 2019 Sep 13;69(7):1120-1129. doi: 10.1093/cid/ciy1064. Clin Infect Dis. 2019. PMID: 30590480 Free PMC article.
References
LinkOut - more resources
Full Text Sources